2011-28240. Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Veterinary Feed Directive  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

    DATES:

    Fax written comments on the collection of information by December 1, 2011.

    ADDRESSES:

    To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, fax: (202) 395-7285, or emailed to oira_submission@omb.eop.gov. All comments should be identified with the OMB control number 0910-0363. Also include the FDA docket number found in brackets in the heading of this document.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Juanmanuel Vilela, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, (301) 796-7651, juanmanuel.vilela@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.

    Veterinary Feed Directive—21 CFR Part 558 (OMB Control Number 0910-0363)—(Extension)

    With the passage of the Animal Drug Availability Act of 1996 (ADAA) (Pub. L. 104-250), the Congress enacted legislation establishing a new class of restricted feed use drugs, veterinary feed directive (VFD) drugs, which may be distributed without involving State pharmacy laws. Although controls on the distribution and use of VFD drugs are similar to those for prescription drugs regulated under section 503(f) of the Federal Food, Drug and Cosmetic Act (21 U.S.C. 353(f)), the implementing VFD regulation (21 CFR 558.6) is tailored to the unique circumstances relating to the distribution of medicated feeds. The content of the VFD is spelled out in the regulation. All distributors of medicated feed containing VFD drugs must notify FDA of their intent to distribute, and records must be maintained of the distribution of all medicated feeds containing VFD drugs. The VFD regulation ensures the protection of public health while enabling animal producers to obtain and use needed drugs as efficiently and cost-effectively as possible.

    In the Federal Register of August 3, 2011(76 FR 46818), FDA published a 60-day notice requesting public comment on the proposed collection of information. FDA received no comments that pertained to the information collection burden estimates.

    FDA estimates the burden of this collection of information as follows:

    Table 1—Estimated Annual Reporting Burden 1

    21 CFR sectionNumber of respondentsNumber of responses per respondentTotal annual responsesAverage burden per responseTotal hours
    558.6(a)(3) through (a)(5)15,00025375,000.2593,750
    558.6(d)(1)(i) through (d)(1)(iii)3001300.2575
    558.6(d)(1)(iv)20120.255
    558.6(d)(2)1,00055,000.251,250
    514.1(b)(9)11133
    Start Printed Page 67461
    Total95,083
    1 There are no capital costs or operating and maintenance costs associated with this collection of information.

    Table 2—Estimated Annual Recordkeeping Burden 1

    21 CFR sectionNumber of RecordkeepersNumber of records per recordkeeperTotal annual recordsAverage burden per recordkeepingTotal hours
    558.6(c)(1) through (c)(4)112,500101,125,000.016718,788
    558.6(e)(1) through (e)(4)5,00075375,000.01676,263
    Total25,051
    1 There are no capital costs or operating and maintenance costs associated with this collection of information.

    The estimate of the times required for record preparation and maintenance is based on Agency communication with industry and Agency records and experience.

    Start Signature

    Dated: October 27, 2011.

    Leslie Kux,

    Acting Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2011-28240 Filed 10-31-11; 8:45 am]

    BILLING CODE 4160-01-P

Document Information

Comments Received:
0 Comments
Published:
11/01/2011
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2011-28240
Dates:
Fax written comments on the collection of information by December 1, 2011.
Pages:
67460-67461 (2 pages)
Docket Numbers:
Docket No. FDA-2011-N-0554
PDF File:
2011-28240.pdf